MDA-19 – synthetic, strong CB2 agonist
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
(abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18666769
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. (full – 2010) http://www.anesthesia-analgesia.org/content/111/1/99.long